An object of the present invention is to provide a compound having a guanidine skeleton which inhibits the protease activity of MALT1 and exerts a therapeutic or prophylactic effect on autoimmune disease such as psoriasis or allergic disease such as atopic dermatitis. The present invention provides a guanidine derivative typified by the following formula or a pharmacologically acceptable salt thereof.